Agibot Medical Technology key facts
- Manufacturer of intelligent surgical robots intended for clinical applications in minimally invasive procedures.
- It has raised $13.9M; the latest was Later Stage VC in Oct 2025.
- Notable investors include Suzhou Oriza Holdings Corporation, Suzhou Guofa Venture Capital, Nantong Zijing Capital, Suzhou Trust, Cenova Capital — 11 tracked in total.
- Status: Privately Held (backing).
Who backs Agibot Medical Technology
11+- ·The complete investor list: 11 names
- ·Watch Agibot Medical Technology: the Monday email on marks, rounds and moves
Agibot Medical Technology funding rounds
No funding rounds for Agibot Medical Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Agibot Medical Technology investors
11 investors are on record for Agibot Medical Technology, including Suzhou Oriza Holdings Corporation, Suzhou Guofa Venture Capital, Nantong Zijing Capital and Suzhou Trust.
About Agibot Medical Technology
Manufacturer of intelligent surgical robots intended for clinical applications in minimally invasive procedures. The company develops and commercialises laparoscopic surgical robots and related systems, integrating mechanics, electronics, optics, computing and software, thereby supporting precise, affordable and user-centred surgical interventions across medical institutions.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2020
- Website
- agibot.cn/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Agibot Medical Technology doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.